Singapore Ministry of Health Selects Qiagen for Avian Flu Solutions
Posted on: Tuesday, 8 January 2008, 15:00 CST
Qiagen, a provider of assay technologies and products, has been awarded an exclusive contract by the Singapore Ministry of Health to supply sample preparation solutions and molecular tests for the specific detection of Influenza H5N1 viruses - better known as avian flu.
For the country's Avian Influenza Preparedness Program Qiagen provides both fully automated and manual sample preparation technologies for the extraction of viral nucleic acids. These are complemented by test kits for specific and sensitive detection of the highly pathogenic Avian Influenza strain. The contract runs for three years and the volume depends on minimum stockpiling levels as well as the level of intensity of the country's surveillance program.
The contract with the Singapore Ministry of Health is the latest supply agreement of Qiagen with public and private institutions engaged in H5N1 surveillance. More than 80 institutes worldwide involved in the surveillance of avian flu infection use procedures and reagents developed and offered by Qiagen.
Peer Schatz, CEO of Qiagen, said: "This new contract is proof not only of the strong confidence of public health organizations in the performance, quality and reliability of Qiagen's products, but also of their trust in the capabilities we as a market leader can provide in terms of logistics and safety of supply. Our global infrastructure enables us to deliver high volumes of products within very short periods of time from multiple manufacturing sites.
"We support the global community in its efforts to expand its early warning systems that can monitor changes in viral infection which could lead to a pandemic. Qiagen is proud to expand this effort by making its products available also to the Singapore Ministry of Health's surveillance program."
Source: Datamonitor
Related Articles
- A Comprehensive Evaluation of the UK Health Foods & Products Market
- Health Enhancement Products Receives Approval to Commence HIV and CRP Clinical Trial in Cameroon
- Cambodia, US Sign MOU for Promoting Cooperation in Health, Avian Influenza
- Society of Prospective Medicine Group Creates Ties With the Institute for Health and Productivity Management
- Health Enhancement Products Announces Laboratory Analysis Indicates PAZ Contains a Substance Associated With Appetite Suppression; The Analysis Showed a Possible Reason for Weight Loss Properties
- Health Enhancement Products Files for Patent Covering ProAlgaZyme Product
- AT&T Wins Major Global Contract From Air Products
- U.S. Army's Night Vision and Electronic Sensors Directorate Awards Markland Technologies, Inc.'s Subsidiary a $3.1 Million Contract for Technology Products and Services
- Horizon Blue Cross Blue Shield of New Jersey Offering Enhanced Consumer Directed Health Care Products
- CorSolutions and DIRECTV Group Focus of CDC Grant Study; Research to Measure Financial and Clinical Benefits of Employer Investment in Workplace Health and Productivity
 |
 |
User Comments (0)
RSS Feeds